Kyverna Therapeutics, Inc. (KYTX) Capital expenditures 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5,000FY2025 · since FY2023: $621,000 → $5,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5,000 | -99.8% |
| FY2024 | $2.2M | +255.1% |
| FY2023 | $621,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice